InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,225.60
(
-0.17%
)
Dow Jones
39,134.76
(
0.77%
)
Brent Oil
84.96
(
-0.06%
)
Bitcoin
64,096.51
(
-1.12%
)
Post# of 5070
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Femto99

Send PM Follow Ignore
Followers 43
Posts 4135
Boards Moderated 0
Alias Born 02/22/2018

Femto99

Re: ANS414 post# 4647

Saturday, 12/05/2020 10:45:00 PM

Saturday, December 05, 2020 10:45:00 PM

Post# of 5070
21%, not half. It is common for shorts to bet on the failure of a research stage biotech. However, with ORLADEYO $500m+ annual sales projection, we are instantly a commercial-stage pharmaceutical. I think the shorts are in bigger trouble than they were expecting.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent BCRX News
More BCRX News
InvestorsHub NewsWire

Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM

ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM

North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM

VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM

Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

Start posting your company's news
Only $200 per official company press release!